QA: Urogen Pharma Ltd in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001668243_2026_Urogen_Pharma_Ltd.pdf

Logs

Graph

Absolute values for 0001668243, Urogen Pharma Ltd

  xvar xval
0 AssetsCurrent 186,024,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 637,000
3 remainder_Assets 13,794,000
4 LiabilitiesCurrent 46,418,000
5 LiabilitiesNoncurrent 122,210,000
6 remainder_Liabilities 137,301,000
7 CostOfGoodsAndServicesSold 14,185,024
8 SellingGeneralAndAdministrativeExpense 214,941,560
9 ResearchAndDevelopmentExpense 66,728,932
10 remainder_Expenses 35,194,654
11 remainder_Revenues 156,762,192
12 remainder_NetIncome 5,230,632
13 remainder_ComprehensiveNetIncome -31,524
  yvar yval
0 Assets 200,455,000
1 Liabilities 305,929,000
2 Expenses 331,050,170
3 Revenues 156,762,192
4 StockholdersEquity -105,474,000
5 NetIncome -169,057,346
6 ComprehensiveNetIncome -169,073,108
7 BaseVar 499,729,259
8 EconomicCapitalRatiobeforeLimitedLiability -1.58
9 EconomicCapitalRatio 1.16

Edgar->Model Mapping

Feature Distribution

Change over Time